NON-SEMINOMATOUS GERM CELL TUMOR
Clinical trials for NON-SEMINOMATOUS GERM CELL TUMOR explained in plain language.
Never miss a new study
Get alerted when new NON-SEMINOMATOUS GERM CELL TUMOR trials appear
Sign up with your email to follow new studies for NON-SEMINOMATOUS GERM CELL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a simple pill keep relapsed testicular cancer at bay?
Disease control Recruiting nowThis study is for people with relapsed germ cell tumors (a type of cancer often in the testicles or ovaries) who have already had high-dose chemotherapy and a stem cell transplant. It tests whether taking a daily oral chemotherapy drug called etoposide for a while after treatment…
Matched conditions: NON-SEMINOMATOUS GERM CELL TUMOR
Phase: PHASE2 • Sponsor: Nabil Adra • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug duo aims to keep relapsed germ cell cancer in check
Disease control Recruiting nowThis study tests whether taking two drugs (zanzalintinib and oral etoposide) after high-dose chemotherapy can help keep relapsed germ cell tumors from growing. About 38 adults whose cancer has not been cured by standard treatments will participate. The goal is to see if this comb…
Matched conditions: NON-SEMINOMATOUS GERM CELL TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC